HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik Rasmussen Selected Research

Angiopoietin-1

9/2016A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors.
6/2015Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors.
6/2010Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik Rasmussen Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 07/2009
6Multiple Myeloma
01/2021 - 12/2003
6Fatigue
10/2020 - 06/2014
3Breast Neoplasms (Breast Cancer)
01/2021 - 08/2015
3Edema (Dropsy)
10/2020 - 06/2014
3Ovarian Neoplasms (Ovarian Cancer)
12/2018 - 05/2012
3Hypertension (High Blood Pressure)
11/2014 - 02/2008
2Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 08/2015
2Exanthema (Rash)
10/2020 - 06/2014
2Bites and Stings (Sting)
10/2020 - 01/2012
2Glioblastoma (Glioblastoma Multiforme)
01/2020 - 01/2019
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 07/2017
2Renal Cell Carcinoma (Grawitz Tumor)
01/2019 - 06/2014
2Prostatic Neoplasms (Prostate Cancer)
12/2018 - 10/2014
2Nausea
10/2017 - 11/2014
2Chronic Hepatitis B
03/2016 - 09/2015
2Infections
09/2015 - 01/2014
2Diarrhea
10/2014 - 06/2014
2Cardiotoxicity
09/2010 - 12/2009
2Disease Progression
06/2010 - 03/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020
1Liposarcoma
01/2020
1Cytopenia
01/2020
1Brain Neoplasms (Brain Tumor)
01/2019
1Glioma (Gliomas)
01/2019
1Triple Negative Breast Neoplasms
12/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2015
1Vomiting
11/2014
1Epistaxis (Nosebleed)
11/2014
1Constipation
11/2014
1Contusions
10/2014
1Atrophy
10/2014
1Wounds and Injuries (Trauma)
01/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2010

Drug/Important Bio-Agent (IBA)

7trebananibIBA
08/2015 - 07/2009
4Paclitaxel (Taxol)FDA LinkGeneric
08/2015 - 06/2010
3Immunoconjugates (Immunoconjugate)IBA
01/2021 - 01/2019
3Angiopoietin-1IBA
09/2016 - 06/2010
2pembrolizumabIBA
01/2021 - 10/2020
2Monoclonal AntibodiesIBA
10/2020 - 01/2018
2Macrophage Colony-Stimulating FactorIBA
10/2020 - 10/2017
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2020 - 10/2017
22- (5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- (1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA
01/2020 - 01/2019
2N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA
12/2018 - 07/2017
2Aurora KinasesIBA
12/2018 - 07/2017
2Cisplatin (Platino)FDA LinkGeneric
12/2018 - 06/2010
2Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2004
2InterferonsIBA
03/2016 - 09/2015
2Interferon-alpha (Interferon Alfa)IBA
09/2015 - 12/2004
2Docetaxel (Taxotere)FDA Link
08/2015 - 06/2010
2Pharmaceutical PreparationsIBA
08/2015 - 06/2015
2Carboplatin (JM8)FDA LinkGeneric
08/2015 - 06/2010
2Melphalan (Alkeran)FDA LinkGeneric
03/2006 - 12/2004
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2021
1abemaciclibIBA
01/2021
1RamucirumabIBA
01/2021
1LigandsIBA
10/2020
1B-Cell Maturation AntigenIBA
10/2020
1epidermal growth factor receptor VIIIIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
01/2019
1AMG 595IBA
01/2019
1trametinibIBA
01/2019
1taxaneIBA
12/2018
1PlatinumIBA
12/2018
1Etoposide (VP 16)FDA LinkGeneric
12/2018
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2018
1Immunoglobulin G (IgG)IBA
01/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2018
1GlucocorticoidsIBA
01/2018
1Alkaline PhosphataseIBA
10/2017
1TIE-2 Receptor (Receptor, TIE 2)IBA
09/2016
1Antiviral Agents (Antivirals)IBA
09/2015
1AMG623 peptibodyIBA
08/2015
1liposomal doxorubicin (Doxil)FDA Link
08/2015
1Capecitabine (Xeloda)FDA Link
08/2015
1Lapatinib (GW572016)FDA Link
08/2015
1Topotecan (Hycamtin)FDA LinkGeneric
08/2015
1Irinotecan (Camptosar)FDA LinkGeneric
08/2015
1Angiopoietin-2IBA
06/2015
1Bevacizumab (Avastin)FDA Link
11/2014
1motesanib diphosphateIBA
11/2014
1AndrogensIBA
10/2014
1MyostatinIBA
10/2014
1AMG 745IBA
10/2014
1Sunitinib (Sutent)FDA Link
06/2014
1Sorafenib (BAY 43-9006)FDA Link
06/2014
1CytokinesIBA
01/2014
1ChemokinesIBA
01/2014
1Tenofovir (Viread)FDA Link
01/2014
1peginterferon alfa-2a (Pegasys)FDA Link
01/2014
1TubulinIBA
09/2010
1GemcitabineFDA Link
06/2010
1Biomarkers (Surrogate Marker)IBA
06/2010
1Hydralazine (Apresoline)FDA LinkGeneric
12/2009
1Troponin IIBA
12/2009

Therapy/Procedure

6Therapeutics
01/2021 - 12/2004
4Drug Therapy (Chemotherapy)
12/2018 - 03/2006
1Castration
12/2018
1Negative-Pressure Wound Therapy
01/2012